Imaging and technologies for prostate cancer: where are we now—where do we go? March 16, 2021 While some approaches have matured, others are still in their infancy. We have learned that Active Surveillance is safe in patients with low-risk prostate cancer while patients with high-risk prostate cancer are best served by a multimodality approach including surgery, radiotherapy, and medical management [1, 2]. In patients with moderate-risk prostate cancer, we are balancing our choice between cancer control and cancer cure. While surgery offers a potential cure for the disease, it also harbors a significant probability for morbidity and complications. Hence many men and their partners value not to impair quality of life as a possible trade-off for a definitive cure. Read the full article here.Source:Springer About Prostate Cancer Imaging Prostate Cancer News Testing & Diagnosis More for you
While some approaches have matured, others are still in their infancy. We have learned that Active Surveillance is safe in patients with low-risk prostate cancer while patients with high-risk prostate cancer are best served by a multimodality approach including surgery, radiotherapy, and medical management [1, 2]. In patients with moderate-risk prostate cancer, we are balancing our choice between cancer control and cancer cure. While surgery offers a potential cure for the disease, it also harbors a significant probability for morbidity and complications. Hence many men and their partners value not to impair quality of life as a possible trade-off for a definitive cure. Read the full article here.Source:Springer
Complete the Survey
